Memantine Augmentation of Targeted Cognitive Training in Schizophrenia
Conditions:   Schizophrenia;   Schizoaffective Disorder Interventions:   Drug: Memantine;   Drug: Placebo Sponsor:   University of California, San Diego Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2021 Category: Research Source Type: clinical trials

Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastases
Condition:   Metastatic Malignant Neoplasm to Brain Interventions:   Radiation: Conformal Whole Brain Radiotherapy with Unilateral Hippocampal Avoidance;   Radiation: Conformal Whole Brain Radiotherapy with Bilateral Hippocampal Avoidance;   Drug: Memantine Hydrochloride Sponsor:   National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2021 Category: Research Source Type: clinical trials